Ascentage Pharma
Ascentage Pharma's Overview
Ascentage Pharma Group Corporation (6855.HK) is a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases. Committed to addressing unmet clinical needs in China and around the world, Ascentage Pharma has established a pipeline of eight clinical-stage drug candidates, including novel inhibitors of apoptosis proteins and next-generation tyrosine kinase inhibitors. The company leverages its proprietary protein-protein interaction and apoptosis-targeted drug discovery platforms.
Where is Ascentage Pharma's Headquarters?
HQ Function
The headquarters serves as the central hub for Ascentage Pharma's global operations, including drug discovery, research and development, manufacturing, and corporate management.
Notable Features:
State-of-the-art research and development laboratories, and manufacturing facilities designed to comply with global GMP (Good Manufacturing Practice) standards.
Work Culture:
A dynamic and innovative environment focused on scientific excellence, collaboration, and addressing unmet medical needs. The culture emphasizes rigorous research, development processes, and a commitment to bringing novel therapies to patients.
HQ Significance:
The Suzhou headquarters is pivotal for Ascentage Pharma's strategic growth, housing its core R&D engine, advanced manufacturing capabilities, and enabling the execution of its global clinical development programs.
Values Reflected in HQ: The headquarters embodies Ascentage Pharma's commitment to innovation, scientific rigor, quality, patient-centricity, and its ambition to become a global leader in novel drug development.
Location:
Ascentage Pharma supports global functions primarily through its operations in China (Suzhou, Shanghai, Beijing, Guangzhou, Hangzhou, Hong Kong), the United States (Rockville, MD), and Australia (Melbourne). Its global presence is characterized by worldwide clinical trial conduct across North America, Europe, Australia, and China, collaborations with international research institutions, and strategic partnerships to advance its innovative drug pipeline for patients globally.
Street Address:
218 Xinghu Street, Suzhou Industrial Park
City:
Suzhou
State/Province:
Jiangsu Province
Country:
P.R. China
Ascentage Pharma's Global Presence
Rockville, Maryland, USA
Address: 9400 Key West Avenue, Suite 260, Rockville, MD 20850, USA
To advance the company's drug pipeline through clinical trials in North America and navigate the US regulatory landscape for potential drug approvals.
Shanghai, P.R. China
Address: Units 101, 201, Building 3, No. 504, Ri Yin Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P.R. China
To manage and expand clinical trial operations across China, foster domestic partnerships, and support the commercialization strategy within the Chinese market.
Beijing, P.R. China
Address: Unit 07, 35F, Office Tower C, Beijing Yintai Centre, No.2 Jianguomenwai Street, Chaoyang District, Beijing 100022, P.R. China
To manage regulatory submissions and approvals for drug candidates in China and maintain relations with key governmental stakeholders.
Buying Intent Signals for Ascentage Pharma
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Ascentage Pharma
As of April 2025, Ascentage Pharma' leadership includes:
Investors of Ascentage Pharma
Ascentage Pharma has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Ascentage Pharma's core C-suite executive team has demonstrated stability, with no major publicly announced new hires or departures prominently reported in the last 12 months. Leadership continuity is crucial for its ongoing clinical development and global strategy.
Technology (Tech Stack) used by Ascentage Pharma
Discover the tools Ascentage Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ascentage Pharma Email Formats and Examples
Ascentage Pharma Group Corporation likely utilizes common corporate email formats. While specific internal patterns can vary, a frequently observed format for companies in the biopharmaceutical sector is the first initial followed by the last name.
[firstinitial][lastname]@ascentagepharma.com
Format
dyang@ascentagepharma.com
Example
75%
Success rate
News and media
Business Wire • May 20, 2024
Ascentage Pharma’s Olverembatinib Granted FDA Fast Track Designation for Treatment of Patients with CML After Failure of Two or More TKIs
Ascentage Pharma announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its novel drug candidate, olverembatinib (HQP1351), for the treatment of adult patients with chronic-phase chronic myeloid leukemia (CML-CP) who are resistant or intolerant to two or more tyrosine kinase inhibitors (TKIs)....more
PR Newswire • April 29, 2024
Ascentage Pharma Presents Latest Results from Four Clinical Trials of Lisaftoclax (APG-2575) at the 2024 EHA Hybrid Congress
Ascentage Pharma announced that it will present the latest clinical results from four studies of lisaftoclax (APG-2575), its novel BCL-2 selective inhibitor, in patients with hematologic malignancies at the European Hematology Association (EHA) 2024 Hybrid Congress. These include promising data in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and acute myeloid leukemia (AML)....more
Ascentage Pharma • March 26, 2024
Ascentage Pharma Announces 2023 Annual Results, Highlighting Robust Growth and Progress in Global Innovation
Ascentage Pharma released its 2023 annual results, reporting significant revenue growth primarily from its first approved product, olverembatinib. The company highlighted progress across its R&D pipeline, global clinical development, and strategic collaborations, underscoring its commitment to addressing unmet medical needs worldwide....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Ascentage Pharma, are just a search away.